妊娠相关高血压疾病的胎儿生长模式:NICHD胎儿生长研究
本研究基于美国12个中心的前瞻性纵向胎儿生长队列(2009-2013年),比较血压正常与妊娠相关高血压疾病孕妇的胎儿生长轨迹。仅发展为重度子痫前期者显示胎儿估计体重和腹围持续减小,且分娩更早、出生体重更低。
要点
- 重度子痫前期组在22-38周胎儿估计体重较血压正常组降低,每周两两比较P<.008。
- 重度子痫前期组在23-31周和33-37周腹围较血压正常组显著减小,P<.04。
- 其他高血压疾病组与血压正常组相比,未观察到估计体重和腹围的持续差异。
核心结论
- 在妊娠相关高血压疾病孕妇中,仅那些最终发展为重度子痫前期者与血压正常孕妇相比表现出显著且持续的胎儿生长差异,即胎儿估计体重和腹围更小。
研究设计与样本
- 基于美国12个中心2009-2013年开展的前瞻性纵向胎儿生长队列研究,分析2462名孕妇。
- 孕龄经8周0天至13周6天超声确认,孕期最多进行6次超声检查。
- 高血压疾病按2002年美国妇产科医师学会指南诊断并分层:重度子痫前期(包括子痫或HELLP综合征)、轻度子痫前期、重度妊娠期高血压、轻度妊娠期高血压、未特指高血压。
- 采用线性混合模型及三次样条计算各组胎儿估计体重及双顶径、头围、腹围、股骨和肱骨长度的生长曲线。
主要发现
- 2296名(93.3%)血压正常,63名(2.6%)轻度妊娠期高血压,54名(2.2%)轻度子痫前期,32名(1.3%)重度子痫前期,17名(0.7%)未特指高血压。
- 重度子痫前期组与血压正常组相比,22至38周胎儿估计体重降低,每周两两比较P值均<.008。
- 重度子痫前期组与无高血压组相比,23-31周和33-37周胎儿腹围显著更小,每周两两比较P值<.04。
- 重度子痫前期组平均分娩孕龄为35.9±3.2周,显著早于其他组(整体P<.0001)。
- 重度子痫前期组出生体重较血压正常组平均低949.5克(95%CI,-1117.7至-781.2克;P<.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fetal growth patterns in pregnancy-associated hypertensive disorders is poorly understood because prospective longitudinal data are lacking. OBJECTIVE: The objective of the study was to compare longitudinal fetal growth trajectories between normotensive women and those with pregnancy-associated hypertensive disorders. STUDY DESIGN: This is a study based on data from a prospective longitudinal cohort study of fetal growth performed at 12 US sites (2009-2013). Project gestational age was confirmed by ultrasound between 8 weeks 0 days and 13 weels 6 days, and up to 6 ultrasounds were performed across gestation. Hypertensive disorders were diagnosed based on 2002 American College of Obstetricians and Gynecologists guidelines and grouped hierarchically as severe preeclampsia (including eclampsia or HELLP [hemolysis, elevated liver enzymes, and low platelet count] syndrome), mild preeclampsia, severe gestational hypertension, mild gestational hypertension, or unspecified hypertension. Women without any hypertensive disorder constituted the normotensive group. Growth curves for estimated fetal weight and individual biometric parameters including biparietal diameter, head circumference, abdominal circumference, and femur and humerus length were calculated for each group using linear mixed models with cubic splines. Global and weekly pairwise comparisons were performed between women with a hypertensive disorder compared with normotensive women to analyze differences while adjusting for confounding variables. Delivery gestational age and birthweights were compared among groups. RESULTS: Of 2462 women analyzed, 2296 (93.3%) were normotensive, 63 (2.6%) had mild gestational hypertension, 54 (2.2%) mild preeclampsia, 32 (1.3%) severe preeclampsia, and 17 (0.7%) unspecified hypertension. Compared with normotensive women, those with severe preeclampsia had estimated fetal weights that were reduced between 22 and 38 weeks (all weekly pairwise values of P < .008). Women with severe preeclampsia compared with those without hypertension also had significantly smaller fetal abdominal circumference between 23-31 and 33-37 weeks' gestation (weekly pairwise values of P < .04). Scattered weekly growth differences were noted on other biometric parameters between these 2 groups. The consistent differences in estimated fetal weight and abdominal circumference were not observed between women with other hypertensive disorders and those who were normotensive. Women with severe preeclampsia delivered significantly earlier (mean gestational age 35.9 ± 3.2 weeks) than the other groups (global P < .0001). Birthweights in the severe preeclampsia group were also significantly lower (mean -949.5 g [95% confidence interval, -1117.7 to -781.2 g]; P < .0001) than in the normotensive group. CONCLUSION: Among women with pregnancy-associated hypertensive disorders, only those destined to develop severe preeclampsia demonstrated a significant and consistent difference in fetal growth (ie, smaller estimated fetal weight and abdominal circumference) when compared with normotensive women.
引用
- Mateus J, Newman RB, Zhang C, et al. Fetal growth patterns in pregnancy-associated hypertensive disorders: NICHD Fetal Growth Studies. Am J Obstet Gynecol. 2019. PMID: 31226296. doi:10.1016/j.ajog.2019.06.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。